awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37964916-6D5E1A2F-8EC1-406A-BCAD-F10B11C011A5
Q37964916-6D5E1A2F-8EC1-406A-BCAD-F10B11C011A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37964916-6D5E1A2F-8EC1-406A-BCAD-F10B11C011A5
Treatment of relapsed or refractory chronic lymphocytic leukemia.
P2860
Q37964916-6D5E1A2F-8EC1-406A-BCAD-F10B11C011A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37964916-6D5E1A2F-8EC1-406A-BCAD-F10B11C011A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
869df2e59665d4417d948188e70f49f33e29f8fc
P2860
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.